A Phase I Trial Testing NAM Expanded Haploidentical or M

Project: Research project

Project Details

Description

A Phase I Trial Testing NAM Expanded Haploidentical or Mismatched Related Donor Natural Killer (NK) Cells followed by a Short Course of IL-2 for the Treatment of Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory CD20+ Non-Hodgkin Lymphoma
StatusActive
Effective start/end date5/9/1611/30/22

Funding

  • GAMIDA CELL LTD.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.